PAX2, PAX8, and PR are correlated with ovarian seromucinous borderline tumor with endometriosis

[11] Gown AM(2021)Immunohistochemical expression of PAX8, PAX2, and cytokeratin in melanomas J Cutan Pathol 48 1246-1250

[12] Barry TS(2012)PAX Genes in Cancer; Friends or Foes? Front Genet 3 6-863

[13] Wheeler DT(2013)PAX2 Expression in Ovarian Cancer Int J Mol Sci 14 6090-1571

[14] Ronnett BM(2009)PAX2 expression in low malignant potential ovarian tumors and low-grade ovarian serous carcinomas Mod Pathol 22 1243-299

[15] Rutgers JKL(2007)Expression of PAX2 in papillary serous carcinoma of the ovary: immunohistochemical evidence of fallopian tube or secondary Mullerian system origin? Mod Pathol 20 856-826

[16] Li N(2008)Expression of pax8 as a useful marker in distinguishing ovarian carcinomas from mammary carcinomas Am J Surg Pathol 32 1566-862

[17] Gou J(2011)Expression of PAX8 in normal and neoplastic tissues: a comprehensive immunohistochemical study Appl Immunohistochem Mol Morphol 19 293-1480

[18] Li L(2011)A comprehensive analysis of PAX8 expression in human epithelial tumors Am J Surg Pathol 35 816-36

[19] Ming X(2020)Ovarian Seromucinous Tumors: Pathogenesis, Morphologic Spectrum, and Clinical Issues Diagnostics (Basel) 10 77-213

[20] Hu TW(2008)Ovarian carcinoma subtypes are different diseases: implications for biomarker studies PLoS Med 5 e232-undefined

[11] Gown AM(2021)Immunohistochemical expression of PAX8, PAX2, and cytokeratin in melanomas J Cutan Pathol 48 1246-1250

[12] Barry TS(2012)PAX Genes in Cancer; Friends or Foes? Front Genet 3 6-863

[13] Wheeler DT(2013)PAX2 Expression in Ovarian Cancer Int J Mol Sci 14 6090-1571

[14] Ronnett BM(2009)PAX2 expression in low malignant potential ovarian tumors and low-grade ovarian serous carcinomas Mod Pathol 22 1243-299

[15] Rutgers JKL(2007)Expression of PAX2 in papillary serous carcinoma of the ovary: immunohistochemical evidence of fallopian tube or secondary Mullerian system origin? Mod Pathol 20 856-826

[16] Li N(2008)Expression of pax8 as a useful marker in distinguishing ovarian carcinomas from mammary carcinomas Am J Surg Pathol 32 1566-862

[17] Gou J(2011)Expression of PAX8 in normal and neoplastic tissues: a comprehensive immunohistochemical study Appl Immunohistochem Mol Morphol 19 293-1480

[18] Li L(2011)A comprehensive analysis of PAX8 expression in human epithelial tumors Am J Surg Pathol 35 816-36

[19] Ming X(2020)Ovarian Seromucinous Tumors: Pathogenesis, Morphologic Spectrum, and Clinical Issues Diagnostics (Basel) 10 77-213

[20] Hu TW(2008)Ovarian carcinoma subtypes are different diseases: implications for biomarker studies PLoS Med 5 e232-undefined